A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Cancer|Breast Cancer|Non-Small Cell Lung Cancer|Acute Myeloid Leukemia (AML)|Multiple Myeloma|Prostate Cancer|Small Cell Lung Cancer|Non-Hodgkins Lymphoma
Interventions: DRUG: ABBV-075|DRUG: Venetoclax
Sponsor: AbbVie